| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.32 | 0.07 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.07 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |